Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020069288 - GRAPIPRANT UNIT DOSAGE FORMS

Publication Number WO/2020/069288
Publication Date 02.04.2020
International Application No. PCT/US2019/053413
International Filing Date 27.09.2019
IPC
A61K 31/4353 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
A61K 31/437 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61P 19/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
CPC
A61K 31/4353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
A61K 31/437
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61P 19/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
Applicants
  • ARRYS THERAPEUTICS, INC. [US]/[US]
  • ASKAT INC. [JP]/[JP]
Inventors
  • MANFREDI, Mark
  • ECSEDY, Jeffrey
  • NAGAHISA, Atsushi
  • OKUMURA, Takako
Agents
  • REID, Andrea L.C.
  • ARICO, Joseph W.
  • FLEMING, Paul R.
  • OH, Euk Charlie
  • SCALTRITO, Donald V.
  • PAGLIA, Danielle M.
  • WANG, Gang
  • PRAIRIE, Nicholas
  • DAVIS, Chad E.
  • STEVENSON, Christian
  • DECHERT LLP
Priority Data
62/737,28527.09.2018US
62/834,51316.04.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) GRAPIPRANT UNIT DOSAGE FORMS
(FR) FORMES POSOLOGIQUES UNITAIRES DE GRAPIPRANT
Abstract
(EN)
The present invention provides grapiprant unit dosage forms, and methods of use thereof for treating a proliferative disorder.
(FR)
La présente invention concerne des formes posologiques unitaires de grapiprant, et des méthodes d’utilisation de celles-ci pour traiter un trouble prolifératif.
Latest bibliographic data on file with the International Bureau